More than 25,000 bottles of chlorthalidone blood pressure medication have been recalled after the tablets failed safety tests. Patients are being urged to contact their pharmacist to check whether their medication is affected.
More than 25,000 bottles of blood pressure medication have been recalled after failing safety tests. Patients are being advised to contact their pharmacist to check their medication.
Inventia Healthcare Limited voluntarily initiated the recall in the US through the Food and Drug Administration (FDA) on September 3. This recall pertained to 13,567 bottles of 25mg chlorthalidone tablets.
Back in June, the same firm issued a recall for 11,460 bottles of the identical drug, bringing the total to 25,027 bottles impacted. Both recalls were triggered for the same reason, according to Healthline .
The FDA enforcement notice stated that the pills failed dissolution specification, meaning they are not releasing the medication into the body as intended.
Chlorthalidone is a ‘water tablet’, or diuretic, commonly used to treat high blood pressure, fluid retention, heart failure, and diabetes insipidus. Typically, patients are instructed to take the pill at breakfast to prevent sleep disruption.
Three batches of the drug, all expiring in April 2027, are included in the recall. The pills are light yellow and bear the number ‘103’ on one side, while the other side is blank.
Specific details of the batches have been disclosed so patients can contact the pharmacy that dispensed their last prescription to check the batch numbers and determine if they are affected by the recall.
The affected batches are:.
- Recall initiated on September 3, 2026; 13,567 bottles affected.
- Recall initiated on June 5, 2026; 11,460 bottles affected.